Research ArticleBehavioral Pharmacology
Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
Lisa R. Gerak
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Vanessa Minervini
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Elizabeth Latham
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Saba Ghodrati
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Katherine V. Lillis
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Jessica Wooden
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Alex Disney
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Stephen M. Husbands
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Charles P. France
Departments of Pharmacology (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.) and Psychiatry (C.P.F.), and Addiction Research, Treatment & Training Center of Excellence (L.R.G., V.M., E.L., S.G., K.V.L., J.W., C.P.F.), University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom (A.D., S.M.H.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBehavioral Pharmacology
Antagonism by MCAM in Rats
Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
Journal of Pharmacology and Experimental Therapeutics November 1, 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
Research ArticleBehavioral Pharmacology
Antagonism by MCAM in Rats
Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
Journal of Pharmacology and Experimental Therapeutics November 1, 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement